A new research paper has been released by Siemens Financial Services (SFS), describing ‘CFO 4.0’, which is the new breed of chief financial officer in the manufacturing industry that needs to drive and enable the digital transformation process.
As the manufacture of biologics takes on increased significance in the pharmaceutical sector, it’s clear to see why GE Healthcare’s KUBio system is growing in popularity. Lu Rahman paid a visit to the company facility in Uppsala to find out more…
The BIA and business intelligence group, Informa, have released their first quarterly financing update on the biotech sector, showing that venture capital financing and follow on financings on the public markets are off to a solid start
Here, we talk with David Davies, whose appointment as the new head of development at Medherant marks the company’s move into clinical development of the ibuprofen TEPI Patch.
This year will be big for Duchenne muscular dystrophy (DMD) as interest in treatments is on the rise and deal activity is increasing, reported data and analytics company, GlobalData.
The Mundipharma network of independent associated companies has expanded its partnership with biopharma company Celltrion Healthcare to now include exclusive distribution rights to trastuzumab biosimilar, Herzuma, in seven EU markets.
In our next instalment of ‘Meet the maker’, the new VP of Europe for The ACG Group, Steven Facer, discusses his past, present and visions of what future holds for pharma.
Ashfield Healthcare Communication’s new president, Doug Burcin, speaks to EPM about family, fun, achievements, challenges and pharma in this latest instalment of ‘Meet the maker’.
Supplier to the pharma, biotech and specialty ingredients markets, Lonza, has expanded its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in the US.
According to Catalyst Corporate Finance, UK service-based pharma businesses involved in ‘smart’ areas of the market are experiencing heightened interest from domestic and international acquirers.
